title: American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections.
authors.forename: P A
authors.initials: PA
authors.lastname: Brunell
authors.forename: J W
authors.initials: JW
authors.lastname: Bass
authors.forename: R S
authors.initials: RS
authors.lastname: Daum
authors.forename: W B
authors.initials: WB
authors.lastname: Gamble
authors.forename: G S
authors.initials: GS
authors.lastname: Giebink
authors.forename: C B
authors.initials: CB
authors.lastname: Hall
authors.forename: G
authors.initials: G
authors.lastname: Peter
authors.forename: S A
authors.initials: SA
authors.lastname: Plotkin
authors.forename: A R
authors.initials: AR
authors.lastname: Hinman
authors.forename: J C
authors.initials: JC
authors.lastname: Petricciani
mesh_terms: D002353:Carrier State / Q000628:therapy; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines; D006801:Humans; D007116:Immunization, Passive; D007223:Infant; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology / Q000635:transmission; D014761:Viral Hepatitis Vaccines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines